pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Cardiology · news · pharmadog
← back to Cardiology
News · Cardiology
332
stories
15d
Opinion: STAT+: Stop asking if AI is good for medicine
stat
15d
Braveheart lands $383M IPO to take Hengrui cardio drug into Phase 3
endpoints
15d
Braveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui
fiercebiotech
15d
Cardiac drug developer Braveheart banks more than $382M in IPO
biopharma dive
16d
Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad
biospace
16d
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A
biospace
16d
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
biospace
16d
5 NextGen winners who went public this year (and which ones are hiring)
biospace
16d
Victory Medical Center Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels
fda medwatch
16d
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
17d
Amgen drops early-stage obesity drug, upping pressure on MariTide
fiercebiotech
17d
KKR inks $5.7B deal to take medtech manufacturing giant Integer private
fiercebiotech
17d
Opinion: How Josée became one of the 7.9% of Québécois who die by assisted suicide
stat
18d
An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.
biopharma dive
18d
Curium strikes up to $8B deal for radiopharma rival Lantheus
fiercebiotech
18d
New York’s assisted-dying law moves forward
stat
18d
Novo’s late-stage IL-6 stumble shakes inflammation space
biospace
18d
Amgen hit with cybersecurity breach, patient data affected
biospace
18d
Opinion: I’m a neurologist. I’ve delivered ALS diagnoses. Then I received one myself
stat
18d
Heart transplant candidates fail if they get too weak. New program tries inpatient prehab
stat
18d
STAT+: Are AI scribes useful tools in medical education, or a crutch that imperils learning?
stat
18d
5 companies advancing ATTR assets in the wake of Wainua’s fail
biospace
21d
Capricor CEO won’t rule out legal action against FDA after negative adcomm
biospace
21d
Novo setback casts doubt on a new way to treat heart disease
biopharma dive
21d
Novo Nordisk rocked by late-stage cardiovascular drug failure
endpoints
21d
Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
biospace
21d
Alnylam absorbs $10.8B blowback after cutting full-year guidance for TTR franchise
biospace
21d
STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study
stat
21d
Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
fiercebiotech
22d
Alnylam plunges as earnings deliver ‘one-two punch’
biopharma dive
← prev
page 3 of 12
next →
